Top
Global and China Drugs for Treatment of Non-small-Cell Lung Cancer Industry 2016 Deep Market Research Report
Category : Pharmaceuticals  | Published Date : Jun-2016 | Pages : 136
enquire GET DISCOUNT
The report

Global and China Drugs for Treatment of Non-small-Cell Lung Cancer Industry

2016 Deep Market Research Report offers comprehensive insights into current market dynamics and emerging industry trends, product definition and main specifications, key manufacturing technology, detailed profiles of major market players along with detailed segmentation and forecasts. An in-depth status of key market dynamics, restraining factors, and industry challenges are offered in the analysis; the factors responsible for the change in competitive landscape scenario and the winning strategies adopted by market players are considered in the report. The study offer detailed quantitative analysis by covering market revenue shares of prominent companies, production share and data, import-export trends and growth prospects of segments in major regions along the forecast period.

The study provides market participants and stakeholders an incisive analysis of the prominent strategies of companies and manufacturers across the globe. The analysis tracks the industry chain and various factors that impact its development. The analysis is useful to investors and stakeholders to gain an insight into crucial factors that affect key market dynamics along with the measures undertaken by top buyers and sellers to add value across industry chain. Recent policy changes, regulatory framework, technological advancements in and China Drugs for Treatment of Non-small-Cell Lung Cancer Industry are considered in detail in the report. The study offers the different market channels adopted by top vendors the strategies adopted by them to consolidate their market share. Furthermore, quantitative analysis includes recent data and statistics on the production and consumption of the various product offerings in the industry. The analysis covers a reliable estimate of various parameters such as cost & profit, supply & demand, and ROI of the major stakeholders.

The study offers a detailed feasibility analysis of marketing channels and the projects associated with them; this will expand the understanding the market status and favorable factors for new entrants. In addition, critical assessment of recent product launches, technological innovations and R&D activities by stakeholders help the market participants to get a strategic analysis of business environment in various regions. The analysis offers data on the funding of major projects on and China Drugs for Treatment of Non-small-Cell Lung Cancer Industry, which will help the market players to know the imminent investment pockets.
Table of Contents

`Global and China Drugs for Treatment of Non-small-Cell Lung Cancer Research Report to 2020
1 Drugs for Treatment of Non-small-Cell Lung Cancer Overview and Each Type
1.1 Product Overview of Drugs for Treatment of Non-small-Cell Lung Cancer
1.1.1 Definition and Product Scope of Drugs for Treatment of Non-small-Cell Lung Cancer
1.1.2 Global Market Size (Value and Volume) of Drugs for Treatment of Non-small-Cell Lung Cancer 2015-2020
1.1.3 China Market Size (Value and Volume) of Drugs for Treatment of Non-small-Cell Lung Cancer 2015-2020
1.2 Product Segments and Price of Each Type
1.2.1 Product Type of Key Manufacturers
1.2.2 Price List of Each Type in 2015 to 2016
1.2.3 Market Share and Growth Rate of Each Type
1.2.4 Avastin Specification and Price in 2015 and 2016
1.2.5 Afatinib Specification and Price in 2015 and 2016
1.2.6 Pemetrexed Specification and Price in 2015 and 2016
1.2.7 Tarceva Specification and Price in 2015 and 2016
1.2.8 Paclitaxel Specification and Price in 2015 and 2016
1.2.9 Compound cantharidin capsule Specification and Price in 2015 and 2016
1.2.10 Gefitinib Specification and Price in 2015 and 2016
1.2.11 Apa imatinib Specification and Price in 2015 and 2016
1.2.12 Crizotinib Specification and Price in 2015 and 2016
1.2.13 Docetaxel Specification and Price in 2015 and 2016
1.2.14 S-1 Specification and Price in 2015 and 2016
1.2.15 Doxorubicin Specification and Price in 2015 and 2016
1.2.16 Gemcitabine Specification and Price in 2015 and 2016
1.2.17 Javanica oil soft capsule Specification and Price in 2015 and 2016
1.2.18 Tagrisso Specification and Price in 2015 and 2016
1.3 Price List (Interviewed) of Each Type for Key Manufacturers in 2015 and 2016
1.3.1 Price List (Interviewed) of Avastin by Key Manufacturers
1.3.2 Price List (Interviewed) of Afatinib by Key Manufacturers
1.3.3 Price List (Interviewed) of Pemetrexed by Key Manufacturers
1.3.4 Price List (Interviewed) of Tarceva by Key Manufacturers
1.3.5 Price List (Interviewed) of Paclitaxel by Key Manufacturers
1.3.6 Price List (Interviewed) of Compound cantharidin capsule by Key Manufacturers
1.3.7 Price List (Interviewed) of Gefitinib by Key Manufacturers
1.3.8 Price List (Interviewed) of Apa imatinib by Key Manufacturers
1.3.9 Price List (Interviewed) of Crizotinib by Key Manufacturers
1.3.10 Price List (Interviewed) of Docetaxel by Key Manufacturers
1.3.11 Price List (Interviewed) of S-1 by Key Manufacturers
1.3.12 Price List (Interviewed) of Doxorubicin by Key Manufacturers
1.3.13 Price List (Interviewed) of Gemcitabine by Key Manufacturers
1.3.14 Price List (Interviewed) of Javanica oil soft capsule by Key Manufacturers
1.3.15 Price List (Interviewed) of Tagrisso by Key Manufacturers
2 Competition Analysis by Manufacturers in Global and China
2.1 Global Market Drugs for Treatment of Non-small-Cell Lung Cancer Sales and Share List of Key Manufacturers 2015 to 2016
2.2 Global Market Drugs for Treatment of Non-small-Cell Lung Cancer Revenue and Share List of Key Manufacturers 2015 to 2016
2.3 Global Drugs for Treatment of Non-small-Cell Lung Cancer Average Price List of Key Manufacturers 2015 to 2016
2.4 China Market Drugs for Treatment of Non-small-Cell Lung Cancer Sales and Share List of Key Manufacturers 2015 to 2016
2.5 China Market Drugs for Treatment of Non-small-Cell Lung Cancer Revenue and Share List of Key Manufacturers 2015 to 2016
2.6 China Drugs for Treatment of Non-small-Cell Lung Cancer Average Price List of Key Manufacturers 2015 to 2016
3 Sales and Revenue Segments of Each Type 2015 to 2016
3.1 Global Sales and Revenue Segments of Each Type 2015 to 2016
3.1.1 Global Sales and Market Share of Each Type 2015 to 2016
3.1.2 Global Revenue and Market Share of Each Type 2015 to 2016
3.2 Avastin Sales and Growth Rate 2015 to 2020
3.3 Afatinib Sales and Growth Rate 2015 to 2020
3.4 Pemetrexed Sales and Growth Rate 2015 to 2020
3.5 Tarceva Sales and Growth Rate 2015 to 2020
3.6 Paclitaxel Sales and Growth Rate 2015 to 2020
3.7 Compound cantharidin capsule Sales and Growth Rate 2015 to 2020
3.8 Gefitinib Sales and Growth Rate 2015 to 2020
3. 9 Apa imatinib Sales and Growth Rate 2015 to 2020
3.10 Crizotinib Sales and Growth Rate 2015 to 2020
3.11 Docetaxel Sales and Growth Rate 2015 to 2020
3.12 S-1 Sales and Growth Rate 2015 to 2020
3.13 Doxorubicin Sales and Growth Rate 2015 to 2020
3.14 Gemcitabine Sales and Growth Rate 2015 to 2020
3.15 Javanica oil soft capsule Sales and Growth Rate 2015 to 2020
3.16 Tagrisso Sales and Growth Rate 2015 to 2020
4 Market Segments and Forecast of Drugs for Treatment of Non-small-Cell Lung Cancer by Regions
4.1 Sales (Consumption) and Forecast of Drugs for Treatment of Non-small-Cell Lung Cancer by Regions 2015-2020
4.1.1 Sales and Forecast of Drugs for Treatment of Non-small-Cell Lung Cancer by Regions 2015-2020
4.1.2 Sales Growth Rate Forecast of Drugs for Treatment of Non-small-Cell Lung Cancer by Regions 2015 to 2020
4.2 Production and Forecast of Drugs for Treatment of Non-small-Cell Lung Cancer by Regions 2015 to 2020
4.2.1 Production and Forecast of Drugs for Treatment of Non-small-Cell Lung Cancer by Regions 2015 to 2020
4.2.2 Production Growth Rate Forecast of Drugs for Treatment of Non-small-Cell Lung Cancer by Regions 2015 to 2020
4.3 US Market Forecast to 2020
4.3.1 US Sales (Consumption), Production, Import and Export of Drugs for Treatment of Non-small-Cell Lung Cancer 2015 to 2020
4.4 Western Europe Market Forecast to 2020
4.4.1 Western Europe Sales (Consumption), Production, Import and Export of Drugs for Treatment of Non-small-Cell Lung Cancer 2015 to 2020
4.5 Japan Market Forecast to 2020
4.5.1 Japan Sales (Consumption), Production, Import and Export of Drugs for Treatment of Non-small-Cell Lung Cancer 2015 to 2020
4.8 China Market Forecast to 2020
4.8.1 China Sales (Consumption), Production, Import and Export of Drugs for Treatment of Non-small-Cell Lung Cancer 2015 to 2020
5 Raw Materials and Applications
5.1 Key Raw Materials and Price Analysis for Avastin
5.1.1 Key Raw Materials for Avastin
5.1.2 Price Forecast of Key Raw Materials for Avastin 2016 to 2021
5.2 Key Raw Materials and Price Analysis for Afatinib
5.2.1 Key Raw Materials for Afatinib
5.2.2 Price Forecast of Key Raw Materials for Afatinib 2016 to 2021
5.3 Key Raw Materials and Price Analysis for Pemetrexed
5.3.1 Key Raw Materials for Pemetrexed
5.3.2 Price Forecast of Key Raw Materials for Pemetrexed 2016 to 2021
5.4 Key Raw Materials and Price Analysis for Tarceva
5.4.1 Key Raw Materials for Tarceva
5.4.2 Price Forecast of Key Raw Materials for Tarceva 2016 to 2021
5.5 Key Raw Materials and Price Analysis for Paclitaxel
5.5.1 Key Raw Materials for Paclitaxel
5.5.2 Price Forecast of Key Raw Materials for Paclitaxel 2016 to 2021
5.6 Key Raw Materials and Price Analysis for Compound cantharidin capsule
5.6.1 Key Raw Materials for Compound cantharidin capsules
5.6.2 Price Forecast of Key Raw Materials for Compound cantharidin capsule 2016 to 2021
5.7 Key Raw Materials and Price Analysis for Gefitinib
5.7.1 Key Raw Materials for Gefitinib
5.7.2 Price Forecast of Key Raw Materials for Gefitinib 2016 to 2021
5.8 Key Raw Materials and Price Analysis for Apa imatinib
5.8.1 Key Raw Materials for Apa imatinib
5.8.2 Price Forecast of Key Raw Materials for Apa imatinib 2016 to 2021
5.9 Key Raw Materials and Price Analysis for Crizotinib
5.9.1 Key Raw Materials for Crizotinib
5.9.2 Price Forecast of Key Raw Materials for Crizotinib 2016 to 2021
5.10 Key Raw Materials and Price Analysis for Docetaxel
5.10.1 Key Raw Materials for Docetaxel
5.10.2 Price Forecast of Key Raw Materials for Docetaxel 2016 to 2021
5.11 Key Raw Materials and Price Analysis for S-1
5.11.1 Key Raw Materials for S-1
5.11.2 Price Forecast of Key Raw Materials for S-1 2016 to 2021
5.12 Key Raw Materials and Price Analysis for Doxorubicin
5.12.1 Key Raw Materials for Doxorubicin
5.12.2 Price Forecast of Key Raw Materials for Doxorubicin 2016 to 2021
5.13 Key Raw Materials and Price Analysis for Gemcitabine
5.13.1 Key Raw Materials for Gemcitabine
5.13.2 Price Forecast of Key Raw Materials for Gemcitabine 2016 to 2021
5.14 Key Raw Materials and Price Analysis for Javanica oil soft capsule
5.14.1 Key Raw Materials for Javanica oil soft capsule
5.14.2 Price Forecast of Key Raw Materials for Javanica oil soft capsule 2016 to 2021
5.15 Key Raw Materials and Price Analysis for Javanica oil soft capsule
5.15.1 Key Raw Materials for Javanica oil soft capsule
5.15.2 Price Forecast of Key Raw Materials for Javanica oil soft capsule 2016 to 2021
5.16 Applications of Avastin
5.17 Applications of Afatinib
5.18 Applications of Pemetrexed
5.19 Applications of Tarceva
5.20 Applications of Paclitaxel
5.21 Applications of Compound cantharidin capsule
5.22 Applications of Gefitinib
5.23 Applications of Apa imatinib
5.24 Applications of Crizotinib
5.25 Applications of Docetaxel
5.26 Applications of S-1
5.27 Applications of Doxorubicin
5.28 Applications of Gemcitabine
5.29 Applications of Javanica oil soft capsule
5.30 Applications of Tagrisso
6 Key Manufacturers Analysis of Drugs for Treatment of Non-small-Cell Lung Cancer
6.1 Roche
6.1.1 Company Basic Information
6.1.2 Avastin (Specification and Price)
6.1.2.1 Avastin 100mg(4ml), Price, Sales Value and Market Share of Roche
6.1.2.2 Avastin 400mg(16ml), Price, Sales Value and Market Share of Roche
6.1.3 Sales Value, Gross Margin 2011-2016
6.1.3.1 Sales Value, Gross Margin and Growth rate of Roche Avastin 100mg(4ml)
6.1.3.2 Sales Value, Gross Margin and Growth rate of Roche Avastin 400mg(16ml)
6.1.4 Interviewee, Name and Contact
6.2 Boehringer Ingelheim GmbH
6.2.1 Company Basic Information
6.2.2 Afatinib (Specification and Price)
6.2.2.1 Afatinib 20mg*30T/box, Price, Sales Value and Market Share of Boehringer Ingelheim GmbH
6.2.2.2 Afatinib 40mg*30T/box, Price, Sales Value and Market Share of Boehringer Ingelheim GmbH
6.2.2.3 Afatinib 40mg*28T/box, Price, Sales Value and Market Share of Boehringer Ingelheim GmbH
6.2.3 Sales Value, Gross Margin 2011-2016
6.2.3.1 Sales Value, Gross Margin and Growth rate of Boehringer Ingelheim GmbH Afatinib 20mg*30T/box
6.2.3.2 Sales Value, Gross Margin and Growth rate of Boehringer Ingelheim GmbH Afatinib 40mg*30T/box
6.2.3.3 Sales Value, Gross Margin and Growth rate of Boehringer Ingelheim GmbH Afatinib 40mg*28T/box
6.2.4 Interviewee, Name and Contact
6.3 Eli Lilly Nederland B.V.
6.3.1 Company Basic Information
6.3.2 Alimta (Specification and Price)
6.3.2.1 Alimta 100mg, Price, Sales Value and Market Share of Eli Lilly
6.3.2.2 Alimta 500mg, Price, Sales Value and Market Share of Eli Lilly
6.3.3 Sales Value, Gross Margin 2011-2016
6.3.3.1 Sales Value, Gross Margin and Growth rate of Eli Lilly Alimta 100mg
6.3.3.2 Sales Value, Gross Margin and Growth rate of Eli Lilly Alimta 500mg
6.3.4 Interviewee, Name and Contact
6.4 Jiangsu Aosaikang Pharmaceutical
6.4.1 Company Basic Information
6.4.2 Pemetrexed (Specification and Price)
6.4.2.1 Pemetrexed 100mg, Price, Sales Value and Market Share of Jiangsu Aosaikang Pharmaceutical
6.4.2.2 Pemetrexed 500mg, Price, Sales Value and Market Share of Jiangsu Aosaikang Pharmaceutical
6.4.3 Sales Value, Gross Margin 2011-2016
6.4.3.1 Sales Value, Gross Margin and Growth rate of Jiangsu Aosaikang Pharmaceutical Pemetrexed100mg
6.4.3.2 Sales Value, Gross Margin and Growth rate of Jiangsu Aosaikang Pharmaceutical Pemetrexed 500mg
6.4.4 Interviewee, Name and Contact
6.5 Shanghai Chemo Wan Bang Biopharma
6.5.1 Company Basic Information
6.5.2 Pemetrexed (Specification and Price)
6.5.2.1 Pemetrexed 100mg, Price, Sales Value and Market Share of Shanghai Chemo Wan Bang Biopharma
6.5.2.2 Pemetrexed 500mg, Price, Sales Value and Market Share of Shanghai Chemo Wan Bang Biopharma
6.5.3 Sales Value, Gross Margin 2011-2016
6.5.3.1 Sales Value, Gross Margin and Growth rate of Shanghai Chemo Wan Bang Biopharma Pemetrexed100mg
6.5.3.2 Sales Value, Gross Margin and Growth rate of Shanghai Chemo Wan Bang Biopharma Pemetrexed 500mg
6.5.4 Interviewee, Name and Contact
6.6 Nanjing Pharmaceutical Factory
6.6.1 Company Basic Information
6.6.2 Pemetrexed (Specification and Price)
6.6.2.1 Pemetrexed 500mg, Price, Sales Value and Market Share of Nanjing Pharmaceutical Factory
6.6.3 Sales Value, Gross Margin 2011-2016
6.6.3.1 Sales Value, Gross Margin and Growth rate of Nanjing Pharmaceutical Factory Pemetrexed 500mg
6.6.4 Interviewee, Name and Contact
6.7 DEZHOU DEYAO PHARMACEUTICAL
6.7.1 Company Basic Information
6.7.2 Pemetrexed (Specification and Price)
6.7.2.1 Pemetrexed 500mg, Price, Sales Value and Market Share of DEZHOU DEYAO PHARMACEUTICAL
6.7.3 Sales Value, Gross Margin 2011-2016
6.7.3.1 Sales Value, Gross Margin and Growth rate of DEZHOU DEYAO PHARMACEUTICAL Pemetrexed 500mg
6.7.4 Interviewee, Name and Contact
6.8 Qilu Pharmaceutical
6.8.1 Company Basic Information
6.8.2 Pemetrexed (Specification and Price)
6.8.2.1 Pemetrexed 100mg, Price, Sales Value and Market Share of Qilu Pharmaceutical
6.8.2.2 Pemetrexed 500mg, Price, Sales Value and Market Share of Qilu Pharmaceutical
6.8.3 Sales Value, Gross Margin 2011-2016
6.8.3.1 Sales Value, Gross Margin and Growth rate of Qilu Pharmaceutical Pemetrexed 100mg
6.8.3.2 Sales Value, Gross Margin and Growth rate of Qilu Pharmaceutical Pemetrexed 500mg
6.8.4 Interviewee, Name and Contact
6.9 Roche
6.9.1 Company Basic Information
6.9.2 Tarceva (Specification and Price)
6.9.2.1 Tarceva 25mg, Price, Sales Value and Market Share of Roche
6.9.2.2 Tarceva 100mg, Price, Sales Value and Market Share of Roche
6.9.2.3 Tarceva 150mg, Price, Sales Value and Market Share of Roche
6.9.3 Sales Value, Gross Margin 2011-2016
6.9.3.1 Sales Value, Gross Margin and Growth rate of Roche Tarceva 25mg
6.9.3.2 Sales Value, Gross Margin and Growth rate of Roche Tarceva 100mg
6.9.3.3 Sales Value, Gross Margin and Growth rate of Roche Tarceva 150mg
6.9.4 Interviewee, Name and Contact
6.10 Celgene
6.10.1 Company Basic Information
6.10.2 Abraxane (Specification and Price)
6.10.2.1 Abraxane 100mg, Price, Sales Value and Market Share of Celgene
6.10.3 Sales Value, Gross Margin 2011-2016
6.10.3.1 Sales Value, Gross Margin and Growth rate of Celgene Abraxane 100mg
6.10.4 Interviewee, Name and Contact
6.11 Abraxis
6.11.1 Company Basic Information
6.11.2 Paclitaxel (Specification and Price)
6.11.2.1 Paclitaxel 100mg, Price, Sales Value and Market Share of Abraxis
6.11.3 Sales Value, Gross Margin 2011-2016
6.11.3.1 Sales Value, Gross Margin and Growth rate of Abraxis Paclitaxel 100mg
6.11.4 Interviewee, Name and Contact
6.12 Ebewe Pharma
6.12.1 Company Basic Information
6.12.2 Paclitaxel (Specification and Price)
6.12.2.1 Paclitaxel 5ml:30mg, Price, Sales Value and Market Share of Ebewe Pharma
6.12.2.2 Paclitaxel 7ml:100mg, Price, Sales Value and Market Share of Ebewe Pharma
6.12.3 Sales Value, Gross Margin 2011-2016
6.12.3.1 Sales Value, Gross Margin and Growth rate of Ebewe Pharma Paclitaxel 5ml:30mg
6.12.3.2 Sales Value, Gross Margin and Growth rate of Ebewe Pharma Paclitaxel 7ml:100mg
6.12.4 Interviewee, Name and Contact
6.13 Hospira
6.13.1 Company Basic Information
6.13.2 Paclitaxel (Specification and Price)
6.13.2.1 Paclitaxel 5ml:30mg, Price, Sales Value and Market Share of Hospira
6.13.2.2 Paclitaxel 25ml:150mg, Price, Sales Value and Market Share of Hospira
6.13.3 Sales Value, Gross Margin 2011-2016
6.13.3.1 Sales Value, Gross Margin and Growth rate of Hospira Paclitaxel 5ml:30mg
6.13.3.2 Sales Value, Gross Margin and Growth rate of Hospira Paclitaxel 25ml:150mg
6.13.4 Interviewee, Name and Contact
6.14 Bristol-Myers Squibb
6.14.1 Company Basic Information
6.14.2 Paclitaxel (Specification and Price)
6.14.2.1 Paclitaxel 5ml:30mg, Price, Sales Value and Market Share of Bristol-Myers Squibb
6.14.2.2 Paclitaxel 7ml:100mg, Price, Sales Value and Market Share of Bristol-Myers Squibb
6.14.3 Sales Value, Gross Margin 2011-2016
6.14.3.1 Sales Value, Gross Margin and Growth rate of Bristol-Myers Squibb Paclitaxel 5ml:30mg
6.14.3.2 Sales Value, Gross Margin and Growth rate of Bristol-Myers Squibb Paclitaxel 7ml:100mg
6.14.4 Interviewee, Name and Contact
6.15 Beijing Union Pharmaceutical Factory
6.15.1 Company Basic Information
6.15.2 Paclitaxel (Specification and Price)
6.15.2.1 Paclitaxel 5ml:30mg, Price, Sales Value and Market Share of Beijing Union Pharmaceutical Factory
6.15.2.2 Paclitaxel 10ml:60mg, Price, Sales Value and Market Share of Beijing Union Pharmaceutical Factory
6.15.3 Sales Value, Gross Margin 2011-2016
6.15.3.1 Sales Value, Gross Margin and Growth rate of Beijing Union Pharmaceutical Factory Paclitaxel 5ml:30mg
6.15.3.2 Sales Value, Gross Margin and Growth rate of Beijing Union Pharmaceutical Factory Paclitaxel 10ml:60mg
6.15.4 Interviewee, Name and Contact
6.16 Yangtze River Pharmaceutical Group
6.16.1 Company Basic Information
6.16.2 Paclitaxel (Specification and Price)
6.16.2.1 Paclitaxel 5ml:30mg, Price, Sales Value and Market Share of Yangtze River Pharmaceutical Group
6.16.2.2 Paclitaxel 7ml:100mg, Price, Sales Value and Market Share of Yangtze River Pharmaceutical Group
6.16.3 Sales Value, Gross Margin 2011-2016
6.16.3.1 Sales Value, Gross Margin and Growth rate of Yangtze River Pharmaceutical Group Paclitaxel 5ml:30mg
6.16.3.2 Sales Value, Gross Margin and Growth rate of Yangtze River Pharmaceutical Group Paclitaxel 7ml:100mg
6.16.4 Interviewee, Name and Contact
6.17 Jiangsu Aosaikang Pharmaceutical
6.17.1 Company Basic Information
6.17.2 Paclitaxel (Specification and Price)
6.17.2.1 Paclitaxel 5ml:30mg, Price, Sales Value and Market Share of Jiangsu Aosaikang Pharmaceutical
6.17.2.2 Paclitaxel 10ml:60mg, Price, Sales Value and Market Share of Jiangsu Aosaikang Pharmaceutical
6.17.3 Sales Value, Gross Margin 2011-2016
6.17.3.1 Sales Value, Gross Margin and Growth rate of Jiangsu Aosaikang Pharmaceutical Paclitaxel 5ml:30mg
6.17.3.2 Sales Value, Gross Margin and Growth rate of Jiangsu Aosaikang Pharmaceutical Paclitaxel 10ml:60mg
6.17.4 Interviewee, Name and Contact
6.18 Guizhou Yibai Pharmaceutical
6.18.1 Company Basic Information
6.18.2 Compound cantharidin capsule (Specification and Price)
6.18.2.1 Compound cantharidin capsule 0.25g, Price, Sales Value and Market Share of Guizhou Yibai Pharmaceutical
6.18.3 Sales Value, Gross Margin 2011-2016
6.18.3.1 Sales Value, Gross Margin and Growth rate of Guizhou Yibai Pharmaceutical Compound cantharidin capsule 0.25g
6.19.4 Interviewee, Name and Contact
6.19 Beijing Oriental Biological Pharmaceutical
6.19.1 Company Basic Information
6.19.2 Compound cantharidin capsule (Specification and Price)
6.19.2.1 Compound cantharidin capsule 0.25g, Price, Sales Value and Market Share of Beijing Oriental Biological Pharmaceutical
6.19.3 Sales Value, Gross Margin 2011-2016
6.19.3.1 Sales Value, Gross Margin and Growth rate of Beijing Oriental Biological Pharmaceutical Compound cantharidin capsule 0.25g
6.19.4 Interviewee, Name and Contact
6.20 Shaanxi Huaxi Pharmaceutical
6.20.1 Company Basic Information
6.20.2 Compound cantharidin capsule (Specification and Price)
6.20.2.1 Compound cantharidin capsule 0.25g, Price, Sales Value and Market Share of Shaanxi Huaxi Pharmaceutical
6.20.3 Sales Value, Gross Margin 2011-2016
6.20.3.1 Sales Value, Gross Margin and Growth rate of Shaanxi Huaxi Pharmaceutical Compound cantharidin capsule 0.25g
6.20.4 Interviewee, Name and Contact
6.21 Shanxi Yellowriver Traditional Chinese Medicine
6.21.1 Company Basic Information
6.21.2 Compound cantharidin capsule (Specification and Price)
6.21.2.1 Compound cantharidin capsule 0.25g, Price, Sales Value and Market Share of Shanxi Yellowriver Traditional Chinese Medicine
6.21.3 Sales Value, Gross Margin 2011-2016
6.21.3.1 Sales Value, Gross Margin and Growth rate of Shanxi Yellowriver Traditional Chinese Medicine Compound cantharidin capsule 0.25g
6.21.4 Interviewee, Name and Contact
6.22 AstraZeneca
6.22.1 Company Basic Information
6.22.2 Iressa (Specification and Price)
6.22.2.1 Iressa 0.25g, Price, Sales Value and Market Share of AstraZeneca
6.22.3 Sales Value, Gross Margin 2011-2016
6.22.3.1 Sales Value, Gross Margin and Growth rate of AstraZeneca Iressa 0.25g
6.22.4 Interviewee, Name and Contact
6.23 JIANG SU HENG RUI MEDICINE
6.23.1 Company Basic Information
6.23. 2 Apa imatinib (Specification and Price)
6.23.2.1 Apa imatinib 0.25g, Price, Sales Value and Market Share of JIANG SU HENG RUI MEDICINE
6.23.2.2 Apa imatinib 0.375g, Price, Sales Value and Market Share of JIANG SU HENG RUI MEDICINE
6.23.2.3 Apa imatinib 0.425g, Price, Sales Value and Market Share of JIANG SU HENG RUI MEDICINE
6.23.3 Sales Value, Gross Margin 2011-2016
6.23.3.1 Sales Value, Gross Margin and Growth rate of JIANG SU HENG RUI MEDICINE Apa imatinib 0.25g
6.23.3.2 Sales Value, Gross Margin and Growth rate of JIANG SU HENG RUI MEDICINE Apa imatinib 0.375g
6.23.3.3 Sales Value, Gross Margin and Growth rate of JIANG SU HENG RUI MEDICINE Apa imatinib 0.425g
6.23.4 Interviewee, Name and Contact
6.24 Pfizer
6.24.1 Company Basic Information
6.24. 2 Xalkori (Specification and Price)
6.24.2.1 Xalkori 200mg, Price, Sales Value and Market Share of Pfizer
6.24.2.2 Xalkori 250mg, Price, Sales Value and Market Share of Pfizer
6.24.3 Sales Value, Gross Margin 2011-2016
6.24.3.1 Sales Value, Gross Margin and Growth rate of Pfizer Xalkori 200mg
6.24.3.2 Sales Value, Gross Margin and Growth rate of Pfizer Xalkori 250mg
6.24.4 Interviewee, Name and Contact
6.25 Sanofi
6.25.1 Company Basic Information
6.25. 2 Taxotere (Specification and Price)
6.25.2.1 Taxotere 2.0ml:80mg, Price, Sales Value and Market Share of Sanofi
6.25.2.2 Taxotere 0.5ml:20mg, Price, Sales Value and Market Share of Sanofi
6.25.3 Sales Value, Gross Margin 2011-2016
6.25.3.1 Sales Value, Gross Margin and Growth rate of Sanofi Taxotere 2.0ml:80mg
6.24.3.2 Sales Value, Gross Margin and Growth rate of Sanofi Taxotere 0.5ml:20m
6.26 JIANG SU HENG RUI MEDICINE
6.26.1 Company Basic Information
6.26. 2 Docetaxel (Specification and Price)
6.26.2.1 Docetaxel 2.0ml:80mg, Price, Sales Value and Market Share of JIANG SU HENG RUI MEDICINE
6.26.2.2 Docetaxel 0.5ml:20mg, Price, Sales Value and Market Share of JIANG SU HENG RUI MEDICINE
6.26.2.3 Docetaxel 1.5ml:60mg, Price, Sales Value and Market Share of JIANG SU HENG RUI MEDICINE
6.26.3 Sales Value, Gross Margin 2011-2016
6.26.3.1 Sales Value, Gross Margin and Growth rate of JIANG SU HENG RUI MEDICINE Docetaxel 2.0ml:80mg
6.26.3.2 Sales Value, Gross Margin and Growth rate of JIANG SU HENG RUI MEDICINE Docetaxel 0.5ml:20mg
6.26.3.3 Sales Value, Gross Margin and Growth rate of JIANG SU HENG RUI MEDICINE Docetaxel 1.5ml:60mg
6.26.4 Interviewee, Name and Contact
6.27 Qilu Pharmaceutical
6.27.1 Company Basic Information
6.27. 2 Docetaxel (Specification and Price)
6.27.2.1 Docetaxel 4.0ml:80mg, Price, Sales Value and Market Share of Qilu Pharmaceutical
6.27.2.2 Docetaxel 0.5ml:20mg, Price, Sales Value and Market Share of Qilu Pharmaceutical
6.27.2.3 Docetaxel 1.0ml:40mg, Price, Sales Value and Market Share of Qilu Pharmaceutical
6.27.3 Sales Value, Gross Margin 2011-2016
6.27.3.1 Sales Value, Gross Margin and Growth rate of Qilu Pharmaceutical Docetaxel 4.0ml:80mg
6.27.3.2 Sales Value, Gross Margin and Growth rate of Qilu Pharmaceutical Docetaxel 0.5ml:20mg
6.27.3.3 Sales Value, Gross Margin and Growth rate of Qilu Pharmaceutical Docetaxel 1.0ml:40mg
6.27.4 Interviewee, Name and Contact
6.28 Shenzhen Main Luck Pharmaceuticals
6.28.1 Company Basic Information
6.28. 2 Docetaxel (Specification and Price)
6.28.2.1 Docetaxel 0.5ml:20mg, Price, Sales Value and Market Share of Shenzhen Main Luck Pharmaceuticals
6.28.2.2 Docetaxel 1.0ml:40mg, Price, Sales Value and Market Share of Shenzhen Main Luck Pharmaceuticals
6.28.3 Sales Value, Gross Margin 2011-2016
6.28.3.1 Sales Value, Gross Margin and Growth rate of Shenzhen Main Luck Pharmaceuticals Docetaxel 0.5ml:20mg
6.28.3.2 Sales Value, Gross Margin and Growth rate of Shenzhen Main Luck Pharmaceuticals Docetaxel 1.0ml:40mg
6.28.4 Interviewee, Name and Contact
6.29 Jiangsu Aosaikang Pharmaceutical
6.29.1 Company Basic Information
6.29. 2 Docetaxel (Specification and Price)
6.29.2.1 Docetaxel 0.5ml:20mg, Price, Sales Value and Market Share of Jiangsu Aosaikang Pharmaceutical
6.29.3 Sales Value, Gross Margin 2011-2016
6.29.3.1 Sales Value, Gross Margin and Growth rate of Jiangsu Aosaikang Pharmaceutical Docetaxel 0.5ml:20mg
6.29.4 Interviewee, Name and Contact
6.30 Taiho
6.30.1 Company Basic Information
6.30. 2 S-1 (Specification and Price)
6.30.2.1 S-1 20mg*42pill, Price, Sales Value and Market Share of Taiho
6.30.2.2 S-1 25mg*36pill, Price, Sales Value and Market Share of Taiho
6.30.3 Sales Value, Gross Margin 2011-2016
6.30.3.1 Sales Value, Gross Margin and Growth rate of Taiho S-1 20mg*42pill
6.30.3.2 Sales Value, Gross Margin and Growth rate of Taiho S-1 25mg*36pill
6.30.4 Interviewee, Name and Contact
6.31 JIANG SU HENG RUI MEDICINE
6.31.1 Company Basic Information
6.31. 2 S-1 (Specification and Price)
6.31.2.1 S-1 20mg*42pill, Price, Sales Value and Market Share of JIANG SU HENG RUI MEDICINE
6.31.2.2 S-1 25mg*36pill, Price, Sales Value and Market Share of JIANG SU HENG RUI MEDICINE
6.31.3 Sales Value, Gross Margin 2011-2016
6.31.3.1 Sales Value, Gross Margin and Growth rate of JIANG SU HENG RUI MEDICINE S-1 20mg*42pill
6.31.3.2 Sales Value, Gross Margin and Growth rate of JIANG SU HENG RUI MEDICINE S-1 25mg*36pill
6.31.4 Interviewee, Name and Contact
6.32 Qilu Pharmaceutical
6.32.1 Company Basic Information
6.32. 2 S-1 (Specification and Price)
6.32.2.1 S-1 20mg*42pill, Price, Sales Value and Market Share of Qilu Pharmaceutical
6.32.2.2 S-1 25mg*36pill, Price, Sales Value and Market Share of Qilu Pharmaceutical
6.32.3 Sales Value, Gross Margin 2011-2016
6.32.3.1 Sales Value, Gross Margin and Growth rate of Qilu Pharmaceutical S-1 20mg*42pill
6.32.3.2 Sales Value, Gross Margin and Growth rate of Qilu Pharmaceutical S-1 25mg*36pill
6.32.4 Interviewee, Name and Contact
6.33 Pfizer
6.33.1 Company Basic Information
6.33. 2 Adriamycin (Specification and Price)
6.33.2.1 Adriamycin 10mg, Price, Sales Value and Market Share of Pfizer
6.33.3 Sales Value, Gross Margin 2011-2016
6.33.3.1 Sales Value, Gross Margin and Growth rate of Pfizer Adriamycin 10mg
6.33.4 Interviewee, Name and Contact
6.34 Shanghai Fudan-Zhangjiang Bio-Pharmaceutical
6.34.1 Company Basic Information
6.34. 2 Doxorubicin (Specification and Price)
6.34.2.1Doxorubicin 10ml:20mg, Price, Sales Value and Market Share of Shanghai Fudan-Zhangjiang Bio-Pharmaceutical
6.34.2.2 Doxorubicin 5ml:10mg, Price, Sales Value and Market Share of Shanghai Fudan-Zhangjiang Bio-Pharmaceutical
6.34.3 Sales Value, Gross Margin 2011-2016
6.34.3.1 Sales Value, Gross Margin and Growth rate of Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Doxorubicin 10ml:20mg
6.34.3.2 Sales Value, Gross Margin and Growth rate of Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Doxorubicin 5ml:10mg
6.34.4 Interviewee, Name and Contact
6.35 Shanxi Powerdone Pharmaceutics
6.35.1 Company Basic Information
6.35. 2 Doxorubicin (Specification and Price)
6.35.2.1Doxorubicin 5ml:10mg, Price, Sales Value and Market Share of Shanxi Powerdone Pharmaceutics
6.35.3 Sales Value, Gross Margin 2011-2016
6.35.3.1 Sales Value, Gross Margin and Growth rate of Shanxi Powerdone Pharmaceutics Doxorubicin 5ml:10mg
6.35.4 Interviewee, Name and Contact
6.36 HISUN
6.36.1 HISUN
6.36. 2 Doxorubicin (Specification and Price)
6.35.2.1Doxorubicin 5ml:10mg, Price, Sales Value and Market Share of HISUN
6.35.2.2Doxorubicin 10ml:50mg, Price, Sales Value and Market Share of HISUN
6.36.3 Sales Value, Gross Margin 2011-2016
6.36.3.1 Sales Value, Gross Margin and Growth rate of HISUN Doxorubicin 5ml:10mg
6.36.3.2 Sales Value, Gross Margin and Growth rate of HISUN Doxorubicin 10ml:50mg
6.36.4 Interviewee, Name and Contact
6.37 CSPC Pharma
6.37.1 CSPC Pharma
6.37. 2 Doxorubicin (Specification and Price)
6.37.2.1Doxorubicin 10ml:20mg, Price, Sales Value and Market Share of CSPC Pharma
6.37.3 Sales Value, Gross Margin 2011-2016
6.37.3.1 Sales Value, Gross Margin and Growth rate of CSPC Pharma Doxorubicin 10ml:20mg
6.37.4 Interviewee, Name and Contact
6.38 Shenzhen Main Luck Pharmaceuticals
6.38.1 Table Shenzhen Main Luck Pharmaceuticals Basic Information List
6.38. 2 Doxorubicin (Specification and Price)
6.38.2.1Doxorubicin 5ml:10mg, Price, Sales Value and Market Share of Shenzhen Main Luck Pharmaceuticals
6.38.3 Sales Value, Gross Margin 2011-2016
6.38.3.1 Sales Value, Gross Margin and Growth rate of Shenzhen Main Luck Pharmaceuticals Doxorubicin 5ml:10mg
6.38.4 Interviewee, Name and Contact
6.39 Shanxi Powerdone Pharmaceutics
6.39.1 Table Shanxi Powerdone Pharmaceutics Basic Information List
6.39. 2 Doxorubicin (Specification and Price)
6.39.2.1Doxorubicin 5ml:10mg, Price, Sales Value and Market Share of Shanxi Powerdone Pharmaceutics
6.39.3 Sales Value, Gross Margin 2011-2016
6.39.3.1 Sales Value, Gross Margin and Growth rate of Shanxi Powerdone Pharmaceutics Doxorubicin 5ml:10mg
6.39.4 Interviewee, Name and Contact
6.40 Eli Lily
6.40.1 Table Eli Lily Basic Information List
6.40. 2 Gemzar (Specification and Price)
6.40.2.1 Gemzar 200mg, Price, Sales Value and Market Share of Eli Lily
6.40.3 Sales Value, Gross Margin 2011-2016
6.40.3.1 Sales Value, Gross Margin and Growth rate of Eli Lily Gemzar 200mg
6.40.4 Interviewee, Name and Contact
6.41 Luoxin Group
6.41.1 Table Luoxin Group Basic Information List
6.41. 2 Gemcitabine (Specification and Price)
6.41.2.1 Gemcitabine 200mg, Price, Sales Value and Market Share of Luoxin Group
6.41.3 Sales Value, Gross Margin 2011-2016
6.41.3.1 Sales Value, Gross Margin and Growth rate of Luoxin Group Gemcitabine 200mg
6.41.4 Interviewee, Name and Contact
6.42 HISUN
6.41.1 Table HISUN Basic Information List
6.42. 2 Gemcitabine (Specification and Price)
6.42.2.1 Gemcitabine 200mg, Price, Sales Value and Market Share of HISUN
6.42.2.2 Gemcitabine 1000mg, Price, Sales Value and Market Share of HISUN
6.42.3 Sales Value, Gross Margin 2011-2016
6.42.3.1 Sales Value, Gross Margin and Growth rate of HISUN Gemcitabine 200mg
6.42.3.2 Sales Value, Gross Margin and Growth rate of HISUN Gemcitabine 1000mg
6.42.4 Interviewee, Name and Contact
6.43 Lkcisen
6.43.1 Table Lkcisen Basic Information List
6.43. 2 Gemcitabine (Specification and Price)
6.43.2.1 Gemcitabine 200mg, Price, Sales Value and Market Share of Lkcisen
6.43.3 Sales Value, Gross Margin 2011-2016
6.43.3.1 Sales Value, Gross Margin and Growth rate of Lkcisen Gemcitabine 200mg
6.43.4 Interviewee, Name and Contact
6.44 Gloria
6.41.1 Table Gloria Basic Information List
6.44. 2 Gemcitabine (Specification and Price)
6.44.2.1 Gemcitabine 200mg, Price, Sales Value and Market Share of Gloria
6.44.2.2 Gemcitabine 1000mg, Price, Sales Value and Market Share of Gloria
6.44.3 Sales Value, Gross Margin 2011-2016
6.44.3.1 Sales Value, Gross Margin and Growth rate of Gloria Gemcitabine 200mg
6.44.3.2 Sales Value, Gross Margin and Growth rate of GloriaGemcitabine 1000mg
6.44.4 Interviewee, Name and Contact
6.43 JARI Pharmaceutical
6.43.1 Table JARI Pharmaceutical Basic Information List
6.43. 2 Gemcitabine (Specification and Price)
6.43.2.1 Gemcitabine 200mg, Price, Sales Value and Market Share of JARI Pharmaceutical
6.43.3 Sales Value, Gross Margin 2011-2016
6.43.3.1 Sales Value, Gross Margin and Growth rate of JARI Pharmaceutical Gemcitabine 200mg
6.43.4 Interviewee, Name and Contact
6.44 Jiangsu Vanguard Pharmaceutical
6.44.1 Table Jiangsu Vanguard Pharmaceutical Basic Information List
6.44. 2 Javanica oil soft capsule (Specification and Price)
6.44.2.1 Javanica oil soft capsule 0.53g, Price, Sales Value and Market Share of Jiangsu Vanguard Pharmaceutical
6.44.3 Sales Value, Gross Margin 2011-2016
6.44.3.1 Sales Value, Gross Margin and Growth rate of Jiangsu Vanguard Pharmaceutical Javanica oil soft capsule 0.53g
6.44.4 Interviewee, Name and Contact
6.45 Zhejiang Tianyitang Pharmaceutical
6.45.1 Table Zhejiang Tianyitang Pharmaceutical Basic Information List
6.45. 2 Javanica oil soft capsule (Specification and Price)
6.45.2.1 Javanica oil soft capsule 0.53g, Price, Sales Value and Market Share of Zhejiang Tianyitang Pharmaceutical
6.45.3 Sales Value, Gross Margin 2011-2016
6.45.3.1 List of Tables and Figures

Figure Picture of Drugs for Treatment of Non-small-Cell Lung Cancer
Figure Global Market Size (Value) of Drugs for Treatment of Non-small-Cell Lung Cancer 2015-2020
Figure Global Market Size (Volume) of Drugs for Treatment of Non-small-Cell Lung Cancer 2015-2020
Figure China Market Size (Value) of Drugs for Treatment of Non-small-Cell Lung Cancer 2015-2020
Figure China Market Size (Volume) of Drugs for Treatment of Non-small-Cell Lung Cancer 2015-2020
Table Product Type of Key Manufacturers
Table Price List of Each Type
Table Market Share of Each Type
Figure Growth Rate of Each Type 2015 to 2016
Figure Picture of Avastin
Table Specification and Price of Avastin in 2015 and 2016
Figure Picture of Afatinib
Table Specification and Price of Afatinib in 2015 and 2016
Figure Picture of Pemetrexed
Table Specification and Price of Pemetrexed in 2015 and 2016
Figure Picture of Tarceva
Table Specification and Price of Tarceva in 2015 and 2016
Figure Picture of Paclitaxel
Table Specification and Price of Paclitaxel in 2015 and 2016
Figure Picture of Compound cantharidin capsule
Table Specification and Price of Compound cantharidin capsule in 2015 and 2016
Figure Picture of Gefitinib
Table Specification and Price of Gefitinib in 2015 and 2016
Figure Picture of Apa imatinib
Table Specification and Price of Apa imatinib in 2015 and 2016
Figure Picture of Crizotinib
Table Specification and Price of Crizotinib in 2015 and 2016
Figure Picture of Docetaxel
Table Specification and Price of Docetaxel in 2015 and 2016
Figure Picture of S-1
Table Specification and Price of S-1 in 2015 and 2016
Figure Picture of Doxorubicin
Table Specification and Price of Doxorubicin in 2015 and 2016
Figure Picture of Gemcitabine
Table Specification and Price of Gemcitabine in 2015 and 2016
Figure Picture of Javanica oil soft capsule
Table Specification and Price of S-1 in 2015 and 2016
Figure Picture of Tagrisso
Table Specification and Price of S-1 in 2015 and 2016
Table Price List (Interviewed) of Avastin by Key Manufacturers in 2015 and 2016
Table Price List (Interviewed) of Afatinib by Key Manufacturers in 2015 and 2016
Table Price List (Interviewed) of Pemetrexed by Key Manufacturers in 2015 and 2016
Table Price List (Interviewed) of Tarceva by Key Manufacturers in 2015 and 2016
Table Price List (Interviewed) of Paclitaxel by Key Manufacturers in 2015 and 2016
Table Price List (Interviewed) of Compound cantharidin capsule by Key Manufacturers in 2015 and 2016
Table Price List (Interviewed) of Gefitinib by Key Manufacturers in 2015 and 2016
Table Price List (Interviewed) of Apa imatinib by Key Manufacturers in 2015 and 2016
Table Price List (Interviewed) of Crizotinib by Key Manufacturers in 2015 and 2016
Table Price List (Interviewed) of Docetaxel by Key Manufacturers in 2015 and 2016
Table Price List (Interviewed) of S-1 by Key Manufacturers in 2015 and 2016
Table Price List (Interviewed) of Doxorubicin by Key Manufacturers in 2015 and 2016
Table Price List (Interviewed) of Gemcitabine by Key Manufacturers in 2015 and 2016
Table Price List (Interviewed) of Javanica oil soft capsule by Key Manufacturers in 2015 and 2016
Table Price List (Interviewed) of Tagrisso by Key Manufacturers in 2015 and 2016
Table Global Market Drugs for Treatment of Non-small-Cell Lung Cancer Sales List of Key Manufacturers 2015 to 2016
Table Global Market Drugs for Treatment of Non-small-Cell Lung Cancer Sales Share List of Key Manufacturers 2015 to 2016
Table Global Market Drugs for Treatment of Non-small-Cell Lung Cancer Revenue List of Key Manufacturers 2015 to 2016
Table Global Market Drugs for Treatment of Non-small-Cell Lung Cancer Revenue Share List of Key Manufacturers 2015 to 2016
Table Global Drugs for Treatment of Non-small-Cell Lung Cancer Average Price List of Key Manufacturers 2015 to 2016
Table China Market Drugs for Treatment of Non-small-Cell Lung Cancer Sales List of Key Manufacturers 2015 to 2016
Table China Market Drugs for Treatment of Non-small-Cell Lung Cancer Sales Share List of Key Manufacturers 2015 to 2016
Table China Market Drugs for Treatment of Non-small-Cell Lung Cancer Revenue List of Key Manufacturers 2015 to 2016
Table China Market Drugs for Treatment of Non-small-Cell Lung Cancer Revenue Share List of Key Manufacturers 2015 to 2016
Table China Drugs for Treatment of Non-small-Cell Lung Cancer Average Price List of Key Manufacturers 2015 to 2016
Table Global Sales of Each Type 2015 to 2016
Table Global Sales Market Share of Each Type 2015 to 2016
Table Global Revenue of Each Type 2015 to 2016
Table Global Revenue Market Share of Each Type 2015 to 2016
Figure Avastin Sales and Growth Rate 2015 to 2020
Figure Afatinib Sales and Growth Rate 2015 to 2020
Figure Pemetrexed Sales and Growth Rate 2015 to 2020
Figure Tarceva Sales and Growth Rate 2015 to 2020
Figure Paclitaxel Sales and Growth Rate 2015 to 2020
Figure Compound cantharidin capsule Sales and Growth Rate 2015 to 2020
Figure Gefitinib Sales and Growth Rate 2015 to 2020
Figure Apa imatinib Sales and Growth Rate 2015 to 2020
Figure Crizotinib Sales and Growth Rate 2015 to 2020
Figure Docetaxel Sales and Growth Rate 2015 to 2020
Figure S-1 Sales and Growth Rate 2015 to 2020
Figure Doxorubicin Sales and Growth Rate 2015 to 2020
Figure Gemcitabine Sales and Growth Rate 2015 to 2020
Figure Javanica oil soft capsule Sales and Growth Rate 2015 to 2020
Figure Tagrisso Sales and Growth Rate 2015 to 2020
Table Sales and Forecast of Drugs for Treatment of Non-small-Cell Lung Cancer by Regions 2015-2020
Figure Sales Growth Rate Forecast of Drugs for Treatment of Non-small-Cell Lung Cancer by Regions 2015 to 2020
Table Production and Forecast of Drugs for Treatment of Non-small-Cell Lung Cancer by Regions 2015 to 2020
Figure Production Growth Rate Forecast of Drugs for Treatment of Non-small-Cell Lung Cancer by Regions 2015 to 2020
Table US Sales, Production, Import and Export of Drugs for Treatment of Non-small-Cell Lung Cancer 2015 to 2020
Table Western Europe Sales, Production, Import and Export of Drugs for Treatment of Non-small-Cell Lung Cancer 2015 to 2020
Table Japan Sales, Production, Import and Export of Drugs for Treatment of Non-small-Cell Lung Cancer 2015 to 2020
Table China Sales, Production, Import and Export of Drugs for Treatment of Non-small-Cell Lung Cancer 2015 to 2020
Table Key Raw Materials for Avastin
Table Price Forecast of Key Raw Materials for Avastin
Table Key Raw Materials for Afatinib
Table Price Forecast of Key Raw Materials for Afatinib
Table Key Raw Materials for Pemetrexed
Table Price Forecast of Key Raw Materials for Pemetrexed
Table Key Raw Materials for Tarceva
Table Price Forecast of Key Raw Materials for Tarceva
Table Key Raw Materials for Paclitaxel
Table Price Forecast of Key Raw Materials for Paclitaxel
Table Key Raw Materials for Compound cantharidin capsule
Table Price Forecast of Key Raw Materials for Compound cantharidin capsule
Table Key Raw Materials for Gefitinib
Table Price Forecast of Key Raw Materials for Gefitinib
Table Key Raw Materials for Apa imatinib
Table Price Forecast of Key Raw Materials for Apa imatinib
Table Key Raw Materials for Crizotinib
Table Price Forecast of Key Raw Materials for Crizotinib
Table Key Raw Materials for Docetaxel
Table Price Forecast of Key Raw Materials for Docetaxel
Table Key Raw Materials for S-1
Table Price Forecast of Key Raw Materials for S-1
Table Key Raw Materials for Doxorubicin
Table Price Forecast of Key Raw Materials for Doxorubicin
Table Key Raw Materials for Gemcitabine
Table Price Forecast of Key Raw Materials for Gemcitabine
Table Key Raw Materials for Javanica oil soft capsule
Table Price Forecast of Key Raw Materials for Javanica oil soft capsule
Table Key Raw Materials for Javanica oil soft capsule
Table Price Forecast of Key Raw Materials for Javanica oil soft capsule
Table Applications of Avastin
Table Applications of Afatinib
Table Applications of Pemetrexed
Table Applications of Tarceva
Table Applications of Paclitaxel
Table Applications of Compound cantharidin capsule
Table Applications of Gefitinib
Table Applications of Apa imatinib
Table Applications of Crizotinib
Table Applications of Docetaxel
Table Applications of S-1
Table Applications of Doxorubicin
Table Applications of Gemcitabine
Table Applications of Javanica oil soft capsule
Table Applications of Tagrisso
Table Roche Basic Information List
Table Boehringer Ingelheim GmbH Basic Information List
Table Eli Lilly Nederland B.V. Basic Information List
Table Jiangsu Aosaikang Pharmaceutical Basic Information List
Table Shanghai Chemo Wan Bang Biopharma Basic Information List
Table Nanjing Pharmaceutical Factory Basic Information List
Table DEZHOU DEYAO PHARMACEUTICAL Basic Information List
Table Qilu Pharmaceutical Basic Information List
Table Roche Basic Information List
Table Celgene Basic Information List
Table Abraxis Basic Information List
Table Ebewe Pharma Basic Information List
Table Hospira Basic Information List
Table Bristol-Myers Squibb Basic Information List
Table Beijing Union Pharmaceutical Factory Basic Information List
Table Yangtze River Pharmaceutical Group Basic Information List
Table Jiangsu Aosaikang Pharmaceutical Basic Information List
Table Guizhou Yibai Pharmaceutical Basic Information List
Table Beijing Oriental Biological Pharmaceutical Basic Information List
Table Shaanxi Huaxi Pharmaceutical Basic Information List
Table Shanxi Yellowriver Traditional Chinese Medicine Basic Information List
Table AstraZeneca Basic Information List
Table JIANG SU HENG RUI MEDICINE Basic Information List
Table Pfizer Basic Information List
Table Sanofi Basic Information List
Table JIANG SU HENG RUI MEDICINE Basic Information List
Table Qilu Pharmaceutical Basic Information List
Table Shenzhen Main Luck Pharmaceuticals Basic Information List
Table Jiangsu Aosaikang Pharmaceutical Basic Information List
Table Taiho Basic Information List
Table JIANG SU HENG RUI MEDICINE Basic Information List
Table Qilu Pharmaceutical Basic Information List
Table Pfizer Basic Information List
Table Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Basic Information List
Table Shanxi Powerdone Pharmaceutics Basic Information List
Table HISUN Basic Information List
Table CSPC Pharma Basic Information List

...
Publisher Name : QYResearch

SIMILAR MARKET STUDIES

Please Select Format
Single User: US $ 2550
Enterprise User: US $ 5100

NEED MORE INFORMATION
Contact us
Call us +1-971-202-1575
--- or ---
help@bigmarketresearch.com
WHY BIG MARKET RESEARCH
With high quality and penned to perfection, Big Market Research is an exclusive online market to get best market research reports for your business needs and strategies. We recommend you to stop browsing as soon as you discover our website. This is because we firmly believe that once you reach here; all your business concerns will be addressed.

We have a huge collection of market research report from numerous filed which will provide you with all the necessary solution. We make sure that reports that we sell are true in context, have a quality that is unrivaled, fully integrated with equal spread of opinion. They will give you proper insights into different opportunities one may locate for their start-up pr expansion.

Let your qualms and concern be sidelined through our high end syndicated as well as customized reports.
Top